Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension

BACKGROUND: Levels of marinobufagenin (MBG), an endogenous bufadienolide Na/K-ATPase (NKA) inhibitor, increase in preeclampsia and in NaCl-sensitive hypertension. METHODS: We tested a 3E9 monoclonal anti-MBG antibody (mAb) for the ability to lower blood pressure (BP) in NaCl-sensitive hypertension a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Fedorova, Olga V., Simbirtsev, Andrey S., Kolodkin, Nikolai I., Kotov, Alexander Y., Agalakova, Natalia I., Kashkin, Vladimir A., Tapilskaya, Natalia I., Bzhelyansky, Anton, Reznik, Vitaly A., Frolova, Elena V., Nikitina, Elena R., Budny, Georgy V., Longo, Dan L., Lakatta, Edward G., Bagrov, Alexei Y.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2008
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2583455/
https://ncbi.nlm.nih.gov/pubmed/19008721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HJH.0b013e328312c86a
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia